Solvent extracts of Butyrivibrio fibrisolvens contain 2-[3, 7, 11, 15-tetramethylhexadecyl]-3, 5, 6-trimethyl-benzoquinol (deoxy-alpha-tocopherolquinol) that can serve as an alternate electron donor for alpha-tocopherolquinol for the biohydrogenation of cis-9, trans-11-octadecadienoate. In addition, the cell extracts contain deoxy-alpha-tocopherolquinone. This compound arises metabolically from alpha-tocopherolquinone via dehydration to trimethylphytylbenzoquinone followed by hydrogenation to deoxy-alpha-tocopherolquinone. Although the hydrogenation of the isoprene double bond and the conjugated fatty acid both use NADH as the primary reductant, the two reactions appear to be catalyzed by different enzymes.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: